BioAlberta and Innovative Medicines Canada Present: Industry Response to COVID-19: Vaccines and Treatments
A global pandemic of unprecedented proportions demands an unprecedented coordinated global response. Since the COVID-19 crisis began, we have seen unprecedented levels of collaboration among pharmaceutical companies, research centres, universities and governments. Learn more about the local and global response and the race to discover, develop and deliver new medicines and vaccines for COVID-19.
Industry Response to COVID-19: Vaccines and Treatments When: June 24, 2020, 11-11:45 AM MDT Register here now. Access to Recorded Webinar!Thanks LifeSciences BC for sharing access to this recorded Webinar & presentations on Navigating the expedited Medical Device Health Canada and FDA processes with our BioAlberta Members. https://lifesciencesbc.ca/eventsoverview/past-events-2/2020-events/ COVID-19 Resouces for MembersDuring these challenging times, BioAlberta has been working for and representing our member companies at provincial and national tables. President Robb Stoddard remains in regular communication with authorities about what Alberta needs now and how the life science sectors can assist with crisis response. Since #COVID19AB began, BioAlberta has worked with our members to identify local companies who can assist both levels of government with production and procurement of supplies needed to fight this viral outbreak. As government programs continue to evolve BioAlberta remains committed to navigating you to the supports you need to advance your business goals and to the growth and health of the life sciences community. We are also committed to helping you effectively cope during this COVID-19 outbreak, personally and professionally. The Government of Canada announced financial aid and important supports for businesses and individuals that can assist you, your family and your employees manage through this trying period of time. To learn more about the COVID-19 Economic Response Plan and how to access evolving financial aid mechanisms see GOC Support. Remember that tax filing deferrals are June 1st for individuals August 31st for corporations. The aid package also designated $25,000 per small business employer to help subsidize wages, a $300 Canada Child Benefit increase and changes to the GST Credit. The Government of Alberta also announced new funding and supportive measures to provide immediate financial relief to Alberta’s families, local businesses and employers. See GOA Support for more details. To stay on top of new developments in what is a rapidly changing health and local information environment, see the links below to connect to both health and other government authorities latest information:
Please contact us if you have any questions or suggestions we should hear about: Robb Stoddard, President and CEO: Robb@bioalberta.com Joshua Lee, Membership Manager: Joshua@bioalberta.com __________________________________________________________________ The National Research Council Canada is offering life science companies the opportunity to register for two programs: NRC COVID-19 Challenge Program & NRC Industrial Research Assistance Program.
|
COVID-19 Impact Survey
|
